About RNA Diagnostics

This author has not yet filled in any details.
So far RNA Diagnostics has created 6 blog entries.

First patient enrolled in BREVITY, Rna Diagnostics’ International Validation Trial of RDA™ in Primary Breast Cancer

Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced enrollment of the first patient in the BREVITY trial at the Azienda Socio-Sanitaria Territoriale di Cremona in Cremona, Italy today. BREVITY (Breast Cancer Response EValuation for Individualized TherapY) […]

By |April 27th, 2018|Uncategorized|Comments Off on First patient enrolled in BREVITY, Rna Diagnostics’ International Validation Trial of RDA™ in Primary Breast Cancer

RDA™ Evolves into Platform Technology

While the primary focus of RNA Disruption Assay (RDA) continues to be breast cancer chemotherapy management, it is rapidly evolving into a platform technology that will be utilized in the management  of  treatments across multiple cancers. RDA is now being employed in clinical trials for […]

By |November 18th, 2015|Uncategorized|0 Comments

RNA Disruption Assay (RDA™ ) appears superior to a pCR as a chemotherapy response biomarker

Rna Diagnostics announces the study, Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy, recently published in Breast Cancer Research and Treatment.

Rna Diagnostics is a Canadian cancer diagnostics company developing diagnostic tools to improve chemotherapy management. The company’s first product, RDA, evaluates early in a woman’s […]

By |September 10th, 2015|Uncategorized|0 Comments

NORCAT Innovation Mill client RNA Diagnostics closes round of angel investment

RNA Diagnostics, a Sudbury-based medical diagnostic company, has successfully closed an additional round of angel investment with support of the NORCAT Innovation Mill Angel group.

RNA Diagnostics, with their patented RNA Disruption Assay™ (RDA™), enables clinicians to identify patients who are not responding to chemotherapy early […]

By |July 31st, 2015|Uncategorized|0 Comments

Rna Diagnostics’ RDA™ To Offer Significant Savings to Healthcare Systems

Interactive cost benefit model shows use of RDA in the neoadjuvant setting cost effective for German payers.

Breast cancer stakeholders attended the 34th Annual Meeting of the German Society for Senology conference featuring up-to-date breast cancer diagnostics and therapies. RDA was represented there via Assessment in […]

By |July 2nd, 2014|Uncategorized|0 Comments

Medical diagnostics company could create more than 50 Sudbury jobs – Northern Life.ca

Rna Diagnostics aims for $150M in revenues by 2019
If all goes according to plan, a Toronto-based medical diagnostics company expects to create more than 50 jobs in Sudbury over the next five years.

Rna Diagnostics’ head office may be in Toronto, but the team of researchers […]

By |May 18th, 2014|Uncategorized|0 Comments